GHR/Growth Hormone R Protein, Human, Recombinant (His)

SKU TMPK-00806-100 μg Category Recombinant-Protein Brand: TargetMol

Price range: 669 CAD through 2,672 CAD

Size

100 μg 500 μg

Clear

Products Details

Product Description

– Pegvisomant, a growth hormone receptor (GHR) antagonist, is a well-known drug that was designed to treat acromegaly. However, recent studies have indicated that the GHR is a “moonlighting” protein that may exhibit dual functions based on its localization in the plasma membrane and nucleus.

For Research Use Only (RUO). This product is sold strictly for laboratory research use only. Not for human or veterinary consumption, therapeutic, or diagnostic use. Any pharmacological, therapeutic, cosmetic, or biological effects described above are provided as research context only and do not represent intended or approved uses of this product.

Web ID

– TMPK-00806

Storage Temperature

– -20℃

Shipping

– Blue Ice

References

– Lan H, et al. Endocytosis and Degradation of Pegvisomant and a Potential New Mechanism That Inhibits the Nuclear Translocation of GHR. J Clin Endocrinol Metab. 2019 Jun 1;104(6):1887-1899. doi: 10.1210/jc.2018-02063. PMID: 30602026.

Molecular Weight

Product type

– Recombinant-Protein

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.